Bioventus launches single-injection joint-fluid OA treatment in Malaysia
Bioventus is launching DUROLANE, its single-injection joint-fluid osteoarthritis (OA) treatment, in Malaysia and has selected Athrotech as its…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
30 Jan 19
Bioventus is launching DUROLANE, its single-injection joint-fluid osteoarthritis (OA) treatment, in Malaysia and has selected Athrotech as its…
25 Jan 19
Becton, Dickinson and Company (BD) has secured 510(k) clearance for its second-generation BD Nano pen needle to optimize…
23 Jan 19
The British Medical Association has warned the UK medical devices sector it will become vulnerable should Britain leave…
23 Jan 19
Medical device firm OrthogenRx has introduced TriVisc (sodium hyaluronate) to treat patients with osteoarthritic (OA) knee pain.
22 Jan 19
Scientists at EPFL and ETH Zurich have developed smart microrobots that are capable of changing their shape depending…
18 Jan 19
Adamis Pharmaceuticals announced that its marketing and commercial partner, Sandoz, a Novartis division, has launched SYMJEPI (epinephrine) 0.3…
18 Jan 19
Medtronic has enrolled first patient in its Embrace targeted drug delivery (TDD) clinical trial designed to assess the…
08 Jan 19
ResMed, a provider of cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, has completed its acquisition of…
28 Nov 18
Teva Pharmaceutical Industries has introduced limited doses of the FDA-approved generic version of EpiPen (epinephrine injection, USP) auto-Injector,…
22 Nov 18
Novartis division Sandoz and Pear Therapeutics have commercially launched reSET, the first and only FDA-authorized prescription digital therapeutic…